DOI QR코드

DOI QR Code

Autophagy: Noble target mechanisms in natural medicines as anticancer agents

자가식세포작용: 천연물항암제로서의 신규작용기전

  • Kang, Se-Chan (Department of Natural Medicine Resources, Semyung University)
  • 강세찬 (세명대학교 자연약재과학과)
  • Received : 2010.02.24
  • Accepted : 2010.03.03
  • Published : 2010.03.31

Abstract

Programmed cell death systems are important for an active type of cell deaths. Among them, a type of programmed cell death, autophagy is activated in cancer cells in response to multiple stresses and has been demonstrated to promote tumor cell survival and drug resistance. Thus, in the area of cancer, over the time frame form around the 1940s to date, of the 155 small molecules, 73% are other than "synthetic", with 47% actually being either "natural products" or "directly derived therefrom". Autophagy has multiple physiological functions in multicellular organisms, including protein degradation and organelle turnover. Genes and proteins that constitute the basic machinery of the autophagic process were first identified in the yeast system and some of their mammalian orthologues have been characterized as well. Numerous oncogenes, including Akt1, Bcl-2, NF1, PDPK1, class I PI3K, PTEN, and Ras and oncosuppressors, inculuding Bec-1, Bif-1, DAPK-1, p53 and UVRAG suppress or promote the autophagy pathway. Regulation of autophagy in tumors is governed by similar principles of the normal cells, only in a much more complicated manner, given the frequently observed abnormal PI3K activation in cancer and the multitude of interactions between the PI3K/AKT/mTOR pathway and other cell signaling cascades, often also deregulated in tumor cells. Autophagy induction by some anticancer agents underlines the potential utility of its induction as a new cancer treatment modality of development for natural medicines.

Keywords

References

  1. Abedin MJ, Wang D Mcdonnell MA, Lehmann U, Kelekar A (2007) Autophagy delays apoototic death in breast cancer cells following DNA damage. Cell Death Differ 14:500-510 https://doi.org/10.1038/sj.cdd.4402039
  2. Abida WM, Gu W (2008) p53-Dependent and p53-independent activation of autophagy by ARF. Cancer Res 68:352-357 https://doi.org/10.1158/0008-5472.CAN-07-2069
  3. Ahlberg J, Yucel T, Eriksson L, Glaumann H (1987) Characterization of the proteolytic compartment in rat hepatocyte nodules. Virchows Arch B Cell Pathol Incl Mol Pathol 53:79-88 https://doi.org/10.1007/BF02890228
  4. Allgayer H, Fulda S (2008) An introduction to molecular targeted therapy of cancer. Advances in medical sciences 53:130-138 https://doi.org/10.2478/v10039-008-0025-9
  5. Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A (2008) Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res 68:1485-1494 https://doi.org/10.1158/0008-5472.CAN-07-0562
  6. Arico S, petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, Ogier-Denis E (2001) The tumor suppressor PTeN positively regulates macroautophay by inhibiting the phosphatidylinoditol 3-kinase/protein kinase Bpathway. J.Biol, Chem 276:35243-35246 https://doi.org/10.1074/jbc.C100319200
  7. Barbara MS, David MR, Peter EL, Ilya R (2007) Revisiting the anient concept of botanical therapeutics. NATURE CHEMICAL BIOLOGY 3:360-366 https://doi.org/10.1038/nchembio0707-360
  8. Canuto RA, Tessitore L, Muzio G, Autelli R, Baccino FM (1993) Tissue protein turnover during liver carcinogenesis. Carcinogenesis 14:2581-2587 https://doi.org/10.1093/carcin/14.12.2581
  9. Canuto RA, Tessitore L, Muzio G, Autelli R, Baccino FM, (1993) Tissue protein turnover during liver carcinogenesis. Carcinogenesis 14:2581-7 https://doi.org/10.1093/carcin/14.12.2581
  10. Carew JS, Nawrocki ST, Kahue CN, Zhang H, Yang C, Chung L, Houghton JA, Huang P, Giles FJ, Cleveland JL (2007) Targeting autophagy auments the anticancer activity of the histone deacetylace inhibitor SAHA to overcome Bcr-Ablmediated drug resistance. Blood 110:313-322 https://doi.org/10.1182/blood-2006-10-050260
  11. Chen G, Burger MM (2004) p150 overexpression in gastric carcinoma: the addociation with p53. Apopotosis and cell proliferation. Int. J. Cancer 84:95-100
  12. Chen N, Karantza-Wadsworth V (2009) Role and regulation of autophagy in cancer. Biochimica et Biophysica Acta 1793:1516-1523 https://doi.org/10.1016/j.bbamcr.2008.12.013
  13. Clarke PG (1990) Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berlin) 181:195-213
  14. Cockle SM, Dean RT (1984) Distinct proteolytic mechanisms in serum-sufficient and serum-restricted fibroblasts. Transformed 3T3 cells fail to regulate proteolysis in relation to culture density only during serum-sufficiency. Biochem J 221:53-60 https://doi.org/10.1042/bj2210053
  15. Cully M, You H, Levine AJ, Mak TW (2006) Byond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6:184-192 https://doi.org/10.1038/nrc1819
  16. Daido S, Kanzawa T, Yamamoto A, Takeuchi H, Kondo Y, Kondo S (2004) Pivotal role of the cell death facor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 64:4286-4293 https://doi.org/10.1158/0008-5472.CAN-03-3084
  17. Dedenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, Nelson DA, Jin S, White E (2006) Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer cell 10:51-64 https://doi.org/10.1016/j.ccr.2006.06.001
  18. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, Mukherjee C, Shi Y, Gelinas C, Fan Y, Nelson DA, Jin S, Whtie E (2006) Autophagy promotes tumor cell surval and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10:51-64 https://doi.org/10.1016/j.ccr.2006.06.001
  19. Edinger AL, Cinalli RM, Thompson CB (2003) Rab7 prevents growth factor independent survival by inhibiting cell-automous nutrient transporter expression. Dev. Cell 5:961-967
  20. Eugenia M, Lorenzo G, Oliver K, Jose-Miguel V, Algredo C, Maria Chiara M, Guido K (2009) Anti- and pro-tumor functions of autophay. Biochimcal et Biophysica Acts 1793:1524-1532 https://doi.org/10.1016/j.bbamcr.2009.01.006
  21. Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, BoloGna M (2005) Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell bissemination. Thromb Haemost 93:964-75
  22. Fulda S, Debatin KM (2004) Targeting apoptosis pathways in cancer therapy. Curr Cancer Durg Targets 4:569-76 https://doi.org/10.2174/1568009043332763
  23. Fulda S, Debatin KM (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Ocecogene 25:8543-67
  24. Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiurl MC, Kroemer G (2008) To die or not to die: that is the autophagic question. Curr 8:78-91
  25. Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23:2891-2906 https://doi.org/10.1038/sj.onc.1207521
  26. Greem JR (2003) Antituomor effects of bisphosphonates. Cancer 97:840-7 https://doi.org/10.1002/cncr.11128
  27. Green JR (2004) Bisphosphonates: preclinical review. Oncologist 4:3-13
  28. Gronostajski RM and Pardee AB (1984) Protein degradation in 3T3 cells and tumorigenic transformed 3T3 cells. J Cell Physiol 119: 127-32 https://doi.org/10.1002/jcp.1041190120
  29. Gunn JM, Clark MG, Knowles SE, Hopgood MF, Ballard FJ (1977) Reduced rates of proteolysis in transformed cells. Nature 266: 58-60 https://doi.org/10.1038/266058a0
  30. Hamacher-Brady A, Brady NR, Logue SE, Sayen MR, Jinno M Kirshenbaum LA, Gottlieb RA, Gustafsson AB (2007) Response to myocardial ischemia/reperfusion injury involves Bnip3 and autophagy. Cell Death Differ 14:146-157 https://doi.org/10.1038/sj.cdd.4401936
  31. Harrison B, Kraus M, Burch L, Stevenc C, Craig A, Gordon-Weeks P, Hupp TR (2008) DAPK-1 binding to a linar peptide motif in MAP1B stimulates autophagy and membrane blebbing. J. Biol. Chem 283:9999-1014 https://doi.org/10.1074/jbc.M706040200
  32. Johnstone RW, Ruefli AA, lowe SW (2002) Apoptosis: alink between cancer therapy. Cell 108:153-64 https://doi.org/10.1016/S0092-8674(02)00625-6
  33. Jonathan R, Green JR (2002) Pharmacologic profile of zoledronic acid: a highly potent inhibitor of bone resorption. Durg Dev Res 55:210-24
  34. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, White E (2007) Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 21:1621-1635 https://doi.org/10.1101/gad.1565707
  35. Kisen GO, Tessitore L, Costelli P, Cordon PB, Schwarze PE, Baccino FM, Seglen PO (1993) Reduced autophagic activity in primary rat hepatocellular carcinoma and ascites hepatoma cells. Carcinogenesis 14:2501-2505 https://doi.org/10.1093/carcin/14.12.2501
  36. Knecht E, Hernandez YJ, Grisolia S (1984) Regulation of lysosomal autophagy in transformed and non-transformed mouse fibroblasts under several growth conditions. Exp Cell Res 154:224-232 https://doi.org/10.1016/0014-4827(84)90682-7
  37. Kwon JY, Cheon SH, Lee HR, Han JY, Kim DI (2009) Production of biopharmaceuticals in transgenic plant cell suspension sultures. J Plant Biotechnol 36:309-319 https://doi.org/10.5010/JPB.2009.36.4.309
  38. Levine B, Sinha S, Kroemer G (2008) Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4:600-606 https://doi.org/10.4161/auto.6260
  39. Liang C, Lee JS, Inn KS, Gack MU, Li Q, Roberts EA, Vergen I, Deretic V, Feng P, Akazawa C, Jung JU (2008) Beclin1-binding UVRAG targets the class C Vps Complex to coordinate autophagosome maturation and endocytic trafficking, Nat. Cell Bio 10:776-787 https://doi.org/10.1038/ncb1740
  40. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, Sligerland JM, Mills GB, (2007) The energy sensing LKB1-AMPK pathway regulates p27(kip 1) phosphorylation mediating the decision to enter autophagy or apoptosis. Net. Cell Biol 9:218-224 https://doi.org/10.1038/ncb1537
  41. Ling C, Lee JS, Inn KS, Gack MU, Li Q, Roberts EA, Vergne I Deretic V, Feng P, Akazawa C, Jung JU (2008) Beclin1-binding UVRaG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Net Cell Biol 10:776-787 https://doi.org/10.1038/ncb1740
  42. Ling XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B, (1999) Induction of autophagy and inhibiton of tumorigenesis by beline 1. Nature 402:672-676 https://doi.org/10.1038/45257
  43. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L (2002) EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 1:445-57 https://doi.org/10.1016/S1535-6108(02)00072-7
  44. Lockwood TD, Minassian IA (1982) Protein turnover and proliferation. Failure of SV-3T3 cells to increase lysosomal proteinases, increase protein degradation and cease net protein accumulation. Biochem J 206:251-258 https://doi.org/10.1042/bj2060251
  45. Lopiccolo Y, Blumenthal Gm, Bernstenin WB, Dennis PA (2008) Targeting the PI3K/ Akt/mTOR pathway: effective combinations and clinical considerations, Drug Resist. Updat 11:32-50 https://doi.org/10.1016/j.drup.2007.11.003
  46. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, Kondo S, Kondo Y, Yu Y, Mills GB, Liao WS, Bast Jr RC (2008) The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J. Clin invest 118: 3917-3929
  47. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, Tasdemir E, Functional G, Troulinaki K, Tavernarakis N, Hickman JA, Geneste O, Kroemer G (2007) Functional and physical interaction between Bcl-X(L) and a BH30like domain in Belin-1. EMBO J 26:2527-2539 https://doi.org/10.1038/sj.emboj.7601689
  48. Marino G, Salvador-Montoliu N, Fueyo A, Knecht E, Mizushima N, Lopezotine C (2007) Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/ autophagun-3. J.Biol Chem 282:18573-18583 https://doi.org/10.1074/jbc.M701194200
  49. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, Chen G, Jin E, White E (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21:1367-1381 https://doi.org/10.1101/gad.1545107
  50. Morselli E, Tasdemir E, Maiuri MC, GAlluzzi L, Kepp O, criollo A, Vicencio JM, Soussi T, Kroemer G (2008) Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 7:3056-3061 https://doi.org/10.4161/cc.7.19.6751
  51. Nan C, Jayanta D (2010) Autophagy and tumorigenesis. FEBS Letters 1-8
  52. Newman DJ, Cragg GD (2007) Natual Products as Sources of New Drug over the Last 25 Years J. Nat. Prod 70:461-477 https://doi.org/10.1021/np068054v
  53. Pattingre S, Levine B (2006) Bcl-2 inhibition of autophagy: a new route to Cancer? Cancer Res. 66:2885-2888 https://doi.org/10.1158/0008-5472.CAN-05-4412
  54. Qadir MA, Kwok B, Dragowska WH, To KH, Le D, Bally MB, Gorski SM (2008) Macroautophgy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization, Breast Cancer Res. Treat.
  55. Ramsey HJiMR, Hayes DN, Fan C, Kozlowski MP, Torrice C, Wu DC, Shimamura T, Prerea SA, Liang MC, Cai D, Naumov GN, Bao L, Contreras CM, Li D, Chen L, Krishnamurthy J, Koivunen J, Chirieac LR, Padera RF, Bronson RT, Lindeman NI, Christiani DC, Lin X, Shapiro GI, Janne PA, Johnson BE, Meyerson M, Kwiatkowski DJ, Castrillon DH, Bardeesy N, Sharpless NE, Wong KK (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448: 807-810 https://doi.org/10.1038/nature06030
  56. Rashmi R, Pillai SG, Vijayalingam S, Ryerse J, Chinnadurai G (2008) BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells. Oncogene 27:1366-1375
  57. Reef S, Kimchi A(2008) Nucleolar p19ARF, unlike mitochondrial smRFA, is incapable of inducing p53-independent autophagy. Autophagy 4:866-869 https://doi.org/10.4161/auto.6691
  58. Reef S, Zalckvar E, Shifman O, Bialik S, Sabanay H, Oren M, Kimchi A (2006) Ashort mitochondrial form of p19ARF induces autophagy and caspase- independent cell death. Mol. Cell 22:463-475 https://doi.org/10.1016/j.molcel.2006.04.014
  59. Rogers MJ, Grodon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cellular and molecular mechanisms of action of biphosphonates. Cancer 88:2961-78 https://doi.org/10.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L
  60. Samaddar JS, Gaddy VT, Duplantier J, Thandavan SP, Shah M, Smith MJ, Browning D, Rawson J, Smith SB, Barrett JT, Schoenlein PV (2008) A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the dwvwlopment of antiestrogen resistance, Mol. Cancer Ther 7:2977-2987 https://doi.org/10.1158/1535-7163.MCT-08-0447
  61. Schwartz RA, Fernandez G, Kotulska K, Jowiakk S (2007) Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J. Am. Acad. Mermatol 57:189-202 https://doi.org/10.1016/j.jaad.2007.05.004
  62. Schwarze PE and Seglen PO (1985) Reduced autophagic activity, improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated rats Exp Cell Res 157: 15-28 https://doi.org/10.1016/0014-4827(85)90148-X
  63. Shaw RJ, Cantley LC (2006) PI(3)K and mTOR signaling controls tumour cell growth. Nature 441: 424-430 https://doi.org/10.1038/nature04869
  64. Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sum M, Sato Y, Liang C, Jung JU, Chenh JQ, Mul JJ, Pledger WJ, Wang HG, (2007) Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Net, Cell Biol 9:1142-1151 https://doi.org/10.1038/ncb1634
  65. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D’amelio M, Criollo A, Morselli E, Zhu C, Harper F, Nannmark U, Samara C, Pinton P, Szabadkai G, Pierron G, Blomgren K, Tavernarakis N, Codogno P, Cecconi F, Kroemer G (2008) Regulation of autophagy by cytoplsdmic p53. Nat. Cell Biol 25:1025-1040
  66. Ueno T, Sato W, horie Y, Komatsu M, Tanida I, Yoshida M, Ohshima S, Mak TW, Watanabe S, Kominami E (2008) Loss of Pten, a tumor suppressor, csuses the strong inhibition of autophagy without affecting LC3 lipidation. Autophagy 4:692-700 https://doi.org/10.4161/auto.6085
  67. Yucel T, Ahlberg J, Glaumann H (1989) Overall proteolysis in perfused and subfractionated chemically induced malignant hepatoma of rat: effects of amino acids. Exp Mol Pathol 50:38-49 https://doi.org/10.1016/0014-4800(89)90055-5